<?xml version="1.0" encoding="UTF-8"?>
<ref id="pntd.0007915.ref044">
 <label>44</label>
 <mixed-citation publication-type="journal">
  <name>
   <surname>Rodrigues-da-Silva</surname>
   <given-names>RN</given-names>
  </name>, 
  <name>
   <surname>Correa-Moreira</surname>
   <given-names>D</given-names>
  </name>, 
  <name>
   <surname>Soares</surname>
   <given-names>IF</given-names>
  </name>, 
  <name>
   <surname>de-Luca</surname>
   <given-names>PM</given-names>
  </name>, 
  <name>
   <surname>Totino</surname>
   <given-names>PRR</given-names>
  </name>, 
  <name>
   <surname>Morgado</surname>
   <given-names>FN</given-names>
  </name>, 
  <etal>et al</etal>
  <article-title>Immunogenicity of synthetic peptide constructs based on PvMSP9E795-A808, a linear B-cell epitope of the P. vivax Merozoite Surface Protein-9</article-title>. 
  <source>Vaccine</source>. 
  <year>2019</year>;
  <volume>37</volume>(
  <issue>2</issue>):
  <fpage>306</fpage>â€“
  <lpage>13</lpage>. 
  <pub-id pub-id-type="doi">10.1016/j.vaccine.2018.10.016</pub-id> .
  <?supplied-pmid 30509693?>
  <pub-id pub-id-type="pmid">30509693</pub-id>
 </mixed-citation>
</ref>
